Strategic Partners
We welcome strategic partners who bring development capability and market access. Our participation model aligns rewards with contributions and milestone success.
Strategic Partners
OrchestratePharma GmbH
Parent company of Celfex AB, assigning the license rights to Celfex AB. OrchestratePharma supports the orchestration of the partnerships and governance needed for Celfex to deliver on its investor promise.
Cellix Biosciences
Designer of the IP behind Celfex — the Fexofenadine intellectual property and scientific partner. Founded by inventor Dr. Mahesh Kandula, Cellix contributes molecular and translational expertise across the development program.
Sanos Group / Blueskin
Danish CRO with years of dermatology experience. Through its dermatology unit Blueskin, Sanos is engaged in clinical strategy and oversight, contributing recognized, industry-leading dermatology experience to Celfex's Phase 2 program.
PartexAI
Clinical risk modeling and business development.
Noah Therapeutics
Full-service Contract Research Organization (India) delivering the Phase 2a/2b bridge clinical trial of topical Fexofenadine under ICH-GCP standards.
Become a Partner
We are actively seeking strategic partners and investors to join us in advancing our dermatology pipeline.
Contact Us